title: [Radiation-induced neuropathies: collateral damage of improved cancer prognosis].
abstract: BACKGROUND
  Because of the improvement of cancer prognosis, long-term damages of treatments become a medical and public health problem. Among the iatrogenic complications, neurological impairment is crucial to consider since motor disability and pain have a considerable impact on quality of life of long cancer survivors. However, radiation-induced neuropathies have not been the focus of great attention. The objective of this paper is to provide an updated review about the radiation-induced lesions of the peripheral nerve system.
  
  
  BACKGROUND
  Radiation-induced neuropathies are characterized by their heterogeneity in both symptoms and disease course. Signs and symptoms depend on the affected structures of the peripheral nerve system (nerve roots, nerve plexus or nerve trunks). Early-onset complications are often transient and late complications are usually progressive and associated with a poor prognosis. The most frequent and well known is delayed radiation-induced brachial plexopathy, which may follow breast cancer irradiation. Radiation-induced lumbosacral radiculoplexopathy is characterized by pure or predominant lower motor neuron signs. They can be misdiagnosed, confused with amyotrophic lateral sclerosis (ALS) or with leptomeningeal metastases since nodular MRI enhancement of the nerve roots of the cauda equina and increased cerebrospinal fluid protein content can be observed. In the absence of specific markers of the link with radiotherapy, the diagnosis of post-radiation neuropathy may be difficult. Recently, a posteriori conformal radiotherapy with 3D dosimetric reconstitution has been developed to link a precise anatomical site to unexpected excess irradiation.
  
  
  CONCLUSIONS
  The importance of early diagnosis of radiation-induced neuropathies is underscored by the emergence of new disease-modifying treatments. Although the pathophysiology is not fully understood, it is already possible to target radiation-induced fibrosis but also associated factors such as ischemia, oxidative stress and inflammation. A phase III trial evaluating the association of pentoxifylline, tocopherol and clodronate (PENTOCLO, NCT01291433) in radiation-induced neuropathies is now recruiting.
authors: Département des maladies du système nerveux, hôpital Pitié-Salpêtrière, groupe hospitalier Pitié-Salpêtrière, 47 boulevard de l'Hôpital, Paris, France. pierre-francois.pradat@psl.aphp.fr
authors: P-F
authors: PF
authors: Pradat
authors: T
authors: T
authors: Maisonobe
authors: D
authors: D
authors: Psimaras
authors: T
authors: T
authors: Lenglet
authors: R
authors: R
authors: Porcher
authors: J-L
authors: JL
authors: Lefaix
authors: S
authors: S
authors: Delanian
mesh_terms: D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D009381:Neoplasms, Radiation-Induced / Q000453:epidemiology / Q000628:therapy; D009422:Nervous System Diseases / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D011379:Prognosis; D011832:Radiation Injuries / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy; D011878:Radiotherapy / Q000009:adverse effects*; D012307:Risk Factors